Insights & Innovators

HEOR

Five Ways to Use Early-Stage Models to Support Your Drug’s Value Proposition

Written by Jennifer Benner. In my previous post, I explored the differences between early- and late-stage economic modeling, including a discussion of the benefits of using early-stage models. In this post, I will examine 5 ways that utilizing early-stage models can benefit drug manufacturers and help produce more efficient, cost-effective drug[…]

ihduserconference-3-300x192
Conferences and Events

Instant Health Data User Conference Showcases Customer-Driven Applications of Real-World Evidence

BHE held its 2018 Instant Health Data (IHD) User’s Conference on Wednesday, March 14th at the Ritz Carlton Hotel in Philadelphia, Pennsylvania. Real-world evidence (RWE) managers and IHD users attended from over a dozen life science companies and payers, representing about one-half of all companies licensing IHD. These researchers regularly use[…]

ICER

ICER Versus NICE: Who Cares About Value-Based Pricing Assessments?

This is my last post in an ICER versus NICE series that examines how ICER’s and NICE’s methodologies for implementing cost-effectiveness (CE) analyses differ. My last post explored how differences in the use of a fixed CE threshold and the application of a narrower CE threshold range may lead to different intervention recommendations. In this[…]

HIMSSsign-300x260
Conferences and Events

Healthcare IT's March Madness: A Recap of HIMSS18

Although the NCAA’s March Madness is just heating up, my own March madness is starting to wind down. For those of us in New England, March’s madness really kicked off with three wild Nor’easters. Fortunately for me, these storms coincided with trips to Las Vegas for the Healthcare Information and Management Systems Society (HIMSS)’s Annual[…]

Instant Health Data

Put reliable, rapid analytics in the hands of more people across your organization

Learn more about Panalgo

Get the story behind our work and our team.